Saluda Medical, (ASX:SLD) — Material Events
ASX:SLD · 4 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Saluda Medical Secures FDA Nod for CAP24 Paddle Lead, Expanding US SCS Market AccessMedium
Saluda Medical gains FDA approval for CAP24 surgical paddle lead, expanding U.S. market reach
30 June 2026
·Regulatory Approval
·85
Saluda Medical Secures CE Approval for EVA™ Technology, Expands Market ReachMedium
Saluda Medical gains European CE approval for EVA™ Sensing Technology, expanding commercial rollout
22 Dec 2025
·Regulatory Approval Announcement
·85
Saluda Medical Raises FY26 Revenue Forecast After Strong Q2 SurgeHigh
Saluda Medical boosts FY26 revenue guidance after strong Q2 growth and ASX IPO
28 Jan 2026
·Quarterly Activity Report and Appendix 4C
·85
No articles in this tier for the last 12 months.
Market Mentions
2
- appeared in market wrap coverage
These are market wrap articles where Saluda Medical, (ASX:SLD) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 27 (29 June -> 3 July) 2026
4 July 2026
Healthcare Wrap - Week 5 (26 Jan -> 30 Jan) 2026
31 Jan 2026